What albumin dose and administration schedule should be used to treat hypotension in a patient after multiple blood transfusions?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 16, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Albumin Dosing for Hypotension After Multiple Blood Transfusions

In patients with hypotension following multiple blood transfusions, albumin is NOT recommended as first-line therapy; crystalloid resuscitation (20-30 mL/kg boluses of balanced crystalloids or normal saline) should be used instead, unless the patient has cirrhosis with sepsis-induced hypotension, in which case 5% albumin at 0.5-1.0 g/kg over 3 hours is preferred. 1, 2, 3

Primary Approach: Crystalloids First

  • Crystalloids are the fluid of choice for initial resuscitation in hypotensive patients, including those who have received multiple transfusions, based on strong recommendations from the Surviving Sepsis Campaign guidelines 1
  • Administer 20-30 mL/kg boluses of balanced crystalloids (lactated Ringer's or Plasma-Lyte) or normal saline over 5-10 minutes, titrated to hemodynamic improvement 1
  • Continue fluid challenge technique as long as hemodynamic parameters (blood pressure, heart rate, pulse pressure variation) continue to improve 1

Exception: Cirrhosis with Sepsis-Induced Hypotension

If the patient has underlying cirrhosis AND sepsis-induced hypotension:

  • Use 5% albumin at 0.5-1.0 g/kg administered over 3 hours as the preferred resuscitation fluid 2, 4
  • This is superior to crystalloids for reversing hypotension and improving short-term survival in this specific population 2
  • Avoid 20% albumin in this setting, as it achieves faster MAP >65 mmHg but requires discontinuation in 22% of patients due to pulmonary complications (pulmonary edema, decreased oxygenation) 4

Critical Safety Considerations

Major risks of albumin administration include:

  • Fluid overload and pulmonary edema, particularly in patients with compromised cardiac or pulmonary function—this is dose-dependent 2, 5
  • Paradoxical hypotension can occur with rapid albumin infusion, especially in patients taking ACE inhibitors (11% incidence in cardiac surgery patients) 6
  • Anaphylactoid reactions including severe hypotension, bronchospasm, and decreased oxygenation, though rare 7
  • In cirrhotic patients with extraperitoneal infections, albumin increases pulmonary edema risk 5-fold (OR 5.17,95% CI 1.62-16.47) 3

When Albumin May Be Considered

Specific indications where albumin has established benefit:

  • Large-volume paracentesis (>5L): 8 g albumin per liter of ascites removed, given as 20% or 25% solution after paracentesis completion 1
  • Spontaneous bacterial peritonitis: 1.5 g/kg within 6 hours of diagnosis, followed by 1.0 g/kg on day 3 1
  • Hepatorenal syndrome type 1: Initial dose 1 g/kg for 2 days (maximum 100 g/day), followed by 20-40 g/day in combination with vasoconstrictors 1

Practical Algorithm

  1. Identify the cause of hypotension: Assess for hypovolemia, sepsis, cardiac dysfunction, or bleeding 3

  2. Determine if cirrhosis is present:

    • No cirrhosis: Use crystalloid boluses 20-30 mL/kg, NOT albumin 1, 2, 3
    • Cirrhosis with sepsis: Use 5% albumin 0.5-1.0 g/kg over 3 hours 2, 4
  3. Monitor for fluid overload: Stop albumin immediately if hepatomegaly or pulmonary rales develop; switch to inotropic support 1

  4. Initiate vasopressors if needed: If MAP remains <65 mmHg after initial fluid resuscitation, begin norepinephrine rather than additional albumin 1

Key Pitfalls to Avoid

  • Do not use albumin to "correct" low serum albumin levels—low albumin is a marker of inflammation and mortality risk, not an indication for infusion 8
  • Do not use albumin routinely in general septic shock—it offers no mortality benefit over crystalloids (RR 0.98,95% CI 0.92-1.06) and costs significantly more 2
  • Do not continue albumin if signs of volume overload appear—switch immediately to diuretics and inotropic support 1
  • Avoid rapid infusion in patients on ACE inhibitors—this increases risk of paradoxical hypotension through bradykinin generation 6

Cost Considerations

  • Albumin costs approximately $130 per 25 g vial in the United States 2
  • Given lack of superiority over crystalloids in most settings, crystalloids should be the default resuscitation fluid except in the specific cirrhosis-sepsis scenario 2, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Albumin Use in Hypotensive Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Albumin Dosing for Hypotensive Blood Pressure Support

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Albumin Administration During Hemodialysis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.